MetLife, Inc.
MET
NYSE·Financial Services·Insurance - Life·Mkt cap $62.8B
$97.62
▼ -1.62%
P/E
23.64
Mkt Cap
$62.8B
52-Wk Range
$67.33–$100.93
52-Week Range
$67.33 - $100.93
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 19.4% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Global Market Presence
- Diversified Product Portfolio
- Strong Financial Stability
- Advanced Risk Management Capabilities
Bear Case
1 risk
- Low volatility (beta 0.8).
Growth
Stable outlook
Digital Transformation Initiatives
Value
Fairly valued vs Life Insurance peers
Momentum
Strong
+17.0% over 3m
Quality
Stable
Strong fundamentals
Dividend
Solid
2.38% yield
Smart-money signal
Who's buying MET right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 4, 2026
AUG 5, 2026
Reported EPS of $2.43 vs $2.30 consensus (+5.7% surprise). Revenue of $19.1B vs $19.7B expected (-3.0%).
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+5.7%
Revenue trend · last 8Q
—
-3%
+15%
-2%
-8%
+29%
+4%
+12%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$18.3B
$18.4B
$18.3B
$17.2B
$16.9B
$23.8B
$19.1B
$19.2B
Margins · last 8Q
Gross
0.0%
Operating
0.0%
Profit
3.8%
Wall Street consensus
12 analysts · 83% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
83%
Hold
17%
Sell
0%
Median Price Target
—
Latest: Morgan Stanley · Aug 24, 2026
vs Industry
How MET stacks vs Insurance - Life
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related